Takeda Pharmaceutical to exit cell therapy research
01/10/2025 14:36
Oct 1 - Japanese drugmaker Takeda Pharmaceutical 4502.T said on Wednesday it will discontinue its cell therapy research and look for a partner to advance candidates under development. (Reporting by Kamal Choudhury in Bengaluru. Editing by Jane Merriman) ((Kamal.Choudhury@thomsonreuters.com; ))
Recent news on Takeda Pharmaceutical
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)